统计剂使用与与年龄相关的听力损失之间的关联的横截面和纵向分析
Lizmarie G Maldonado1, Lois J Matthews2, Katharine A Fernandez3
1Department of Healthcare Leadership and Management, Medical University of South Carolina, Charleston, SC, USA.
Drugs & aging
|December 3, 2025
概括
类药物可能有利于中年成年人的听力,特别是对于高频率. 然而,这种与年龄相关的听力损失 (ARHL) 的好处在老年人和随着时间的推移而减少.
科学领域:
- 听力学 听力学是指听力学.
- 老年学是指老年学的学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 类药物在预防噪音和药物引起的听力损失方面表现出潜在的潜力.
- 关于他类药物对与年龄相关的听力损失 (ARHL) 进行保护的证据不一致.
- 在一般人群中对他类药物的使用和ARHL的纵向研究很少.
研究的目的:
- 调查他类药物使用与ARHL之间的关联.
- 分析不同年龄组和频率的他类药物对听力的影响.
- 为了检查与他类药物使用相关的听力纵向变化.
主要方法:
- 1239名55岁以上的参与者来自纵向队列研究.
- 年度听力测量和他类药物使用数据的收集.
- 多变量回归和混合效应模型分析纯色平均值 (PTA).
主要成果:
- 在55-74岁的成年人中,使用静止剂与更好的基线听力 (广泛和高频率PTA) 相相关.
- 在75岁以上的参与者或纵向分析中没有发现这种益处.
- 阿托瓦斯塔丁表现出类似的趋势,但西姆瓦斯塔丁没有.
结论:
- 在ARHL的早期阶段,他类药物可能对中高频听力有好处.
- 需要进一步进行经过良好控制的临床试验.
- 研究特定类型的他类药物及其对一般人群ARHL的影响.
相关概念视频
Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
Longitudinal Studies
449
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
449
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
183
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
183
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
221
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
221
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
212
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
212


